Patents by Inventor Alan Schmaljohn

Alan Schmaljohn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060251681
    Abstract: Using the MBGV GP, NP, and virion proteins, a method and composition for use in inducing an immune response which is protective against infection with MBGV in nonhuman primates is described.
    Type: Application
    Filed: July 12, 2006
    Publication date: November 9, 2006
    Inventors: Michael Heyey, Diane Negley, Peter Pushko, Jonathan Smith, Alan Schmaljohn
  • Publication number: 20050266023
    Abstract: In this application are described filovirus-like particles for both Ebola and Marburg and their use as a diagnostic and therapeutic agent as well as a filovirus vaccine. Also described is the association of Ebola and Marburg with lipid rafts during assembly and budding, and the requirement of functional rafts for entry of filoviruses into cells.
    Type: Application
    Filed: April 13, 2005
    Publication date: December 1, 2005
    Inventors: Sina Bavari, M. Aman, Alan Schmaljohn, Kelly Warfield, Dana Swenson
  • Patent number: 6200959
    Abstract: An approach to genetic vaccine methodology is described. A genetic construction encoding antigenic determinants of a filovirus is transfected into cells of the vaccinated individuals using a particle acceleration protocol so as to express the viral antigens in healthy cells to produce an immune response to those antigens.
    Type: Grant
    Filed: December 4, 1996
    Date of Patent: March 13, 2001
    Assignee: PowerJect Vaccines Inc.
    Inventors: Joel R. Haynes, Connie S. Schmaljohn, Deborah L. Fuller, Alan Schmaljohn, Peter B. Jahrling